JUN and Peritoneal Fibrosis: In vitro silencing of c-Jun reduces mesothelial-to-mesenchymal transition markers (e.g., fibronectin) and fibrin deposition by 60% in bile-induced peritonitis models, underscoring the critical role of AP-1 in peritoneal fibrosis [79].